Back
PDF Solutions 10K Form
Sell
38
PDFS
PDF Solutions
Last Price:
$28.03
Seasonality Move:
-1.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | PDFS/PDF Solutions Quarterly |
2023-11-08 | 10Q | PDFS/PDF Solutions Quarterly |
2023-08-08 | 10Q | PDFS/PDF Solutions Quarterly |
2023-05-09 | 10Q | PDFS/PDF Solutions Quarterly |
2022-11-10 | 10Q | PDFS/PDF Solutions Quarterly |
2022-08-11 | 10Q | PDFS/PDF Solutions Quarterly |
Receive PDFS News And Ratings
See the #1 stock for the next 7 days that we like better than PDFS
PDFS Financial Statistics
Sales & Book Value
Annual Sales: | $165.8M |
---|---|
Cash Flow: | $4.7M |
Price / Cash Flow: | 167.27 |
Annual Sales: | $6.20 |
Price / Book: | 4.52 |
Profitability
EPS (TTM): | 0.11000 |
---|---|
Net Income (TTM): | $4.4M |
Gross Margin: | $114.1M |
Return on Equity: | 1.92% |
Return on Assets: | 1.5% |
PDF Solutions Earnings Forecast
Key PDF Solutions Financial Ratios
-
The Gross Profit Margin over the past 24 years for PDFS is 68.79%.
-
The Selling, General & Administrative Expenses for PDFS have been equal to 37.52% of Gross Profit Margin.
-
The Research & Development expenses have been 30.59% of Revenue.
-
The Interest Expense is -3.15% of Operating Income.
-
The Net Earning history of PDFS is 1.87% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 12 years.
PDF Solutions Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | PDFS |
CUSIP: | 693282 |
Website: | pdf.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.32 |
Quick Ratio: | 2.89 |
Price-to-Earnings
Trailing P/E Ratio: | 350.63 |
---|---|
Forward P/E Ratio: | 27.77 |
PDFS Technical Analysis vs Fundamental Analysis
Sell
38
PDF Solutions (PDFS)
is a Sell
Is PDF Solutions a Buy or a Sell?
-
PDF Solutions stock is rated a SellThe current PDF Solutions [PDFS] share price is $28.05. The Score for PDFS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.